In addition, increased expression of tumor-related inflammatory mediators and cytokines, such as TNF-α, IL-1, and IL-6 may stimulate the bone marrow to release neutrophils, resulting in an increase in the circulating neutrophil count and decrease in the circulating lymphocytopenia [29]. This evidence concerns the gene IL1B and neoplasm.